Literature DB >> 22522123

Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells.

Hsiu-Chuan Chou1, Ying-Chieh Lu, Chao-Sheng Cheng, Yi-Wen Chen, Ping-Chiang Lyu, Cheng-Wen Lin, John F Timms, Hong-Lin Chan.   

Abstract

Berberine is a natural product isolated from herbal plants such as Rhizoma coptidis which has been shown to have anti-neoplastic properties. However, the effects of berberine on the behavior of breast cancers are largely unknown. To determine if berberine might be useful in the treatment of breast cancer and its cytotoxic mechanism, we analyzed the impact of berberine treatment on differential protein expression and redox regulation in human breast cancer cell line MCF-7 using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis (2D-DIGE) combined with mass spectrometry (MS). This study demonstrated that 96 and 22 protein features were significantly changed in protein expression and thiol reactivity, respectively and revealed that berberine-induced cytotoxicity in breast cancer cells involves dysregulation of protein folding, proteolysis, redox regulation, protein trafficking, cell signaling, electron transport, metabolism and centrosomal structure. Our work shows that this combined proteomic strategy provides a rapid method to study the molecular mechanisms of berberine-induced cytotoxicity in breast cancer cells. The identified targets may be useful for further evaluation as potential targets in breast cancer therapy.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522123     DOI: 10.1016/j.jprot.2012.03.010

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  13 in total

Review 1.  Targeting proteomics to investigate metastasis-associated mitochondrial proteins.

Authors:  Hsiu-Chuan Chou; Hong-Lin Chan
Journal:  J Bioenerg Biomembr       Date:  2012-12       Impact factor: 2.945

2.  Fluconazole assists berberine to kill fluconazole-resistant Candida albicans.

Authors:  De-Dong Li; Yi Xu; Da-Zhi Zhang; Hua Quan; Eleftherios Mylonakis; Dan-Dan Hu; Ming-Bang Li; Lan-Xue Zhao; Liang-Hua Zhu; Yan Wang; Yuan-Ying Jiang
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

3.  Interaction of 9-O-(ω-amino) alkyl ether berberine analogs with poly(dT)·poly(dA)*poly(dT) triplex and poly(dA)·poly(dT) duplex: a comparative study.

Authors:  Debipreeta Bhowmik; Gopinatha Suresh Kumar
Journal:  Mol Biol Rep       Date:  2013-05-12       Impact factor: 2.316

4.  Proteomics analysis reveals a potential new target protein for the lipid-lowering effect of Berberine8998.

Authors:  Cheng-Yin Yu; Gang-Yi Liu; Xiao-Hui Liu; Yu-Zhou Gui; Hai-Ming Liu; Hong-Chao Zheng; Darek C Gorecki; Asmita V Patel; Chen Yu; Yi-Ping Wang
Journal:  Acta Pharmacol Sin       Date:  2018-04-12       Impact factor: 6.150

5.  Effect of glutathione reductase knockdown in response to UVB-induced oxidative stress in human lung adenocarcinoma.

Authors:  Hsiu-Chuan Chou; Hong-Lin Chan
Journal:  Proteome Sci       Date:  2014-01-09       Impact factor: 2.480

6.  Quercetin-induced cardioprotection against doxorubicin cytotoxicity.

Authors:  Jing-Yi Chen; Ren-Yu Hu; Hsiu-Chuan Chou
Journal:  J Biomed Sci       Date:  2013-12-20       Impact factor: 8.410

7.  Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer.

Authors:  Yi-Wen Lo; Szu-Ting Lin; Shing-Jyh Chang; Chia-Hao Chan; Kevin W Lyu; Jo-Fan Chang; Eugenie Wong Soon May; Dai-Ying Lin; Hsiu-Chuan Chou; Hong-Lin Chan
Journal:  J Cell Mol Med       Date:  2015-01-30       Impact factor: 5.310

8.  Caenorhabditis elegans as a model system to study post-translational modifications of human transthyretin.

Authors:  Andrea Henze; Thomas Homann; Isabelle Rohn; Michael Aschner; Christopher D Link; Burkhard Kleuser; Florian J Schweigert; Tanja Schwerdtle; Julia Bornhorst
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

Review 9.  Recent Advance in Applications of Proteomics Technologies on Traditional Chinese Medicine Research.

Authors:  Qing Ji; Fangshi Zhu; Xuan Liu; Qi Li; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

10.  A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine.

Authors:  Kuen-Haur Lee; Hsiang-Ling Lo; Wan-Chun Tang; Heidi Hao-yun Hsiao; Pei-Ming Yang
Journal:  Sci Rep       Date:  2014-09-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.